Developer docs
API playgroundTry for free, no card

Search company profiles

PharmaVOICE

Full company profile

uuid0007iw3

Namestring
PharmaVOICE
Legal namestring
TechTarget, Inc.
Websiteurl
pharmavoice.com
Company typeenum
Private
Founded yearint
2001
Descriptiontext

PharmaVoice is a B2B digital media trade publication providing daily news, exclusive Q&A interviews, executive Profiles, and feature editorial to pharmaceutical and biotech industry professionals. Founded in 2001 and co-founded by Taren Grom (Editor-in-Chief Emeritus), the publication is operated by Informa TechTarget, a subsidiary of UK-listed Informa PLC, with operational headquarters in Needham, Massachusetts (headcount 11-50). The platform organizes content across eight topic verticals — Biotech, Commercialization, Leadership, Manufacturing, Patient, Pharma, Policy & Regulation, and Research & Development — and runs recurring series including First 90 Days, Trailblazers, Biotech Spotlight, A Day in the Life, and Opinion. The publication also operates the Library, a sponsored-content hub featuring playbooks, eBooks, webinars, and infographics from third-party sponsors including IQVIA, Cardinal Health, Certara, WCG, Premier Research, Lonza, Resilience, and Quest Diagnostics. Distribution is digital-only via the PharmaVoice website, a free daily newsletter, and social channels including LinkedIn, Facebook, and X.

The business model is sales-led advertising: PharmaVoice sells display advertising, sponsored editorial placements, and event listing promotions to pharmaceutical companies, CROs, biotech firms, and life sciences service providers seeking access to its professional readership. Content is free to readers with no paywall; monetization is entirely advertiser-funded. Revenue streams include display and digital advertising, sponsored content/branded content, event promotion and listings, and the free newsletter used as a lead-generation mechanism for advertisers. PharmaVoice sits within Informa TechTarget's life sciences media portfolio alongside sister publications BioPharma Dive and Xtelligent Pharma Life Sciences, benefiting from shared sales infrastructure and cross-brand audience reach. In 2025, the publication discontinued its annual PharmaVoice 100 recognition program and transitioned to year-round editorial coverage of standout industry leaders.

Short descriptiontext

PharmaVoice is a B2B digital media trade publication operated by Informa TechTarget that delivers daily news, Q&A interviews, and executive profiles to pharmaceutical and biotech industry professionals, monetized via display advertising and sponsored content.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersWashington, United States
HQ citystring
Washington
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pharmaceutical industry news, biotech editorial coverage, B2B trade media, sponsored content publishing, executive Q&A interviews
Industry1 code
PRIMARYEDAGAGAA
Medical & Clinical Reference (Physicians, Nursing, Allied Health)
Education/Educational Publishing & Learning Content/Professional & Technical Reference Publishing
NAICS code2 codes
  • Periodical Publishers513120
  • Other Publishers51319
SIC code1 code
  • Services-Advertising Agencies7311
Product category
B2B Trade Media (Pharmaceutical & Biotech)
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model4 records
1Display and digital advertising
TypeAdvertising
Description

PharmaVoice sells digital advertising placements including banner ads, sponsored content, and branded editorial features to pharma and biotech companies, CROs, and life sciences vendors seeking to reach industry professionals.

pharmavoice.com
2Sponsored content and branded content
TypeAdvertising
Description

The publication features sponsored reports, playbooks, webinars, and infographics from third-party sponsors including pharmaceutical services companies (IQVIA, Cardinal Health, Certara, WCG, Premier Research, Lonza, etc.), presented within the PharmaVoice Library section.

pharmavoice.com
3Event promotion and listings
TypeAdvertising
Description

PharmaVoice promotes industry events (conferences, forums) on its Events page and sells event listing services to organizers, driving revenue through event promotion fees.

pharmavoice.com
4Free newsletter (lead generation)
TypeAdvertising
Description

PharmaVoice offers a free daily newsletter delivering top industry headlines, which serves as a primary lead generation and audience retention mechanism, supporting the advertising business model.

pharmavoice.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Marketing or Sales, Operations, Technology or R&D, Others
GTM typeB2B
B2B
Offering typeDigital Commerce or Conte…
Digital Commerce or Content
Core offering1 text field

PharmaVoice is a digital-first B2B trade media publication that delivers pharmaceutical and biotech industry news, exclusive Q&A interviews with executives, opinion and editorial features, and a sponsored content library to pharma and biotech professionals worldwide. It operates a free daily newsletter and an annual PharmaVoice 100 recognition program, with revenue generated from display advertising, sponsored content, and event promotion sold to pharma advertisers and service providers.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

PharmaVOICE is a digital pharmaceutical industry news publication operated by Informa TechTarget. The platform delivers comprehensive coverage through multiple content sections including news articles, Q&A interviews with industry leaders, executive profiles, Biotech Spotlight features on emerging companies, and the First 90 Days series profiling executives in new roles. The publication organizes content across key topic areas including Biotech, Commercialization, Leadership, Manufacturing, Patient topics, Policy & Regulation, and Research & Development. Supporting offerings include Library Resources (whitepapers and industry reports), Events listings, Press Releases, and the PharmaVoice 100 recognition program honoring industry leaders. The platform serves pharma and biotech professionals seeking industry news, insights, and perspectives.

Product and service5 records
1PharmaVoice Digital News Platform
CategoryTrade media / editorial publication
Description

A digital, editorially driven pharmaceutical and biotech industry news publication distributed freely via pharmavoice.com across eight topic areas: Biotech, Commercialization, Leadership, Manufacturing, Patient, Pharma, Policy & Regulation, and Research & Development. It serves C-suite executives, R&D leaders, and clinical research professionals with news, Q&A interviews, executive profiles, opinion pieces, and trend coverage.

2PharmaVoice Daily Newsletter
CategoryEmail newsletter
Description

A free daily email newsletter delivering top pharmaceutical and biotech industry headlines and featured stories. It functions as the publication's primary audience acquisition and retention channel and supports the advertiser-funded business model.

3PharmaVoice 100 Recognition Program
CategoryAwards and recognition program
Description

An annual nomination-driven recognition program honoring 100 outstanding leaders across 10 categories: Standout Leaders, Clinical Trial Pros, Trailblazers, Patient Champions, Biotech Pathfinders, Cancer Care Visionaries, Cardiometabolic All-stars, Cell and Gene Therapy Pioneers, Rare Disease Warriors, and Tech and AI Wizards. Historically received hundreds of nominations annually.

4PharmaVoice Library (Sponsored Content Hub)
CategorySponsored content / lead generation resource
Description

A sponsored content resource hub on pharmavoice.com that hosts whitepapers, playbooks, webinars, infographics, and eBooks produced by pharma services sponsors. Sold as branded editorial placements to advertisers seeking lead generation and thought leadership reach with pharma decision-makers.

5PharmaVoice Events Listings and Promotion
CategoryEvent promotion and listings
Description

A listing and promotional service on the PharmaVoice Events page for industry conferences and forums (e.g., Cardiovascular Forum, Oncology Forum, AnalytiCon), driving audience registration for event organizers through PharmaVoice's newsletter and editorial reach.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership13 partners
Strategic tierCoreTypeOthers
Description

PharmaVoice is owned and operated by Informa TechTarget, a global media network that informs, influences, and connects technology buyers and sellers. Informa TechTarget provides the operational infrastructure, advertising sales organization, and publishing platform for PharmaVoice. PharmaVoice is part of a portfolio that includes BioPharma Dive, Xtelligent Pharma Life Sciences, and other industry publications within the Informa PLC group.

Strategic tierCoreTypeOthers
Description

Informa TechTarget is a subsidiary of Informa PLC, a UK-based international events, scholarly publishing, and information company. Informa PLC provides corporate ownership, brand backing, and strategic direction for TechTarget's media properties including PharmaVoice.

Strategic tierMinorTypeOthers
Description

BioPharma Dive is another publication under the Informa TechTarget umbrella, covering biotech and pharma news. The two publications share the same parent company and together form a broader pharma and biotech media network within TechTarget.

4Xtelligent Pharma Life Sciences
Strategic tierMinorTypeOthers
Description

Xtelligent Pharma Life Sciences is another publication within the Informa TechTarget network covering pharma and life sciences topics. It is co-branded alongside PharmaVoice on the TechTarget network page.

pharmavoice.com
Strategic tierMinorTypeGTM or Marketing Partner
Description

IQVIA sponsors content on PharmaVoice's Library page, including a playbook titled 'Translating Obesity Research to De-Risk Future GLP-1 Trials.' This is a paid content sponsorship arrangement where IQVIA provides educational content to PharmaVoice's audience.

Strategic tierMinorTypeGTM or Marketing Partner
Description

Cardinal Health sponsors an infographic on PharmaVoice's Library page titled 'Linked real-world data: More context, more completeness.' This is a sponsored content arrangement where Cardinal Health provides educational content to PharmaVoice's pharma professional audience.

Strategic tierMinorTypeGTM or Marketing Partner
Description

Quest Diagnostics sponsors predictive analytics content on PharmaVoice's Commercialization topic page, promoting diagnostic insights as launch strategies for pharma companies.

Strategic tierMinorTypeGTM or Marketing Partner
Description

Certara sponsors an eBook on PharmaVoice's Library page titled 'Rethinking Animal Testing and Drug Development,' providing educational content to the pharma R&D audience.

Strategic tierMinorTypeGTM or Marketing Partner
Description

WCG sponsors multiple content pieces on PharmaVoice's Library page, including playbooks on protocol design and data-informed clinical trial design, as well as an infographic on IRB submission checklists.

Strategic tierMinorTypeGTM or Marketing Partner
Description

Premier Research sponsors playbooks on PharmaVoice's Library page covering topics including the single pivotal clinical trial era and strategies for avoiding costly protocol amendments.

Strategic tierMinorTypeGTM or Marketing Partner
Description

Lonza sponsors a webinar on PharmaVoice's Library page titled 'Scaling Microbial Early Decisions into Commercial Readiness,' providing educational content on manufacturing and bioprocess topics.

12Resilience (National Resilience Inc.)
Strategic tierMinorTypeGTM or Marketing Partner
Description

Resilience sponsors CAR-T manufacturing content on PharmaVoice's Library page, including a sponsored Q&A on DAR-T platform technology for cell therapy manufacturing and an article on integrated data systems for clinical development.

pharmavoice.com
Strategic tierMinorTypeGTM or Marketing Partner
Description

The Health Management Academy (HMAcademy) partners with PharmaVoice to promote its Cardiovascular Forum and Oncology Forum events on PharmaVoice's Events page. PharmaVoice serves as a promotional channel for HMAcademy's industry events.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

BioCentury is a B2B intelligence and news publication focused on the biotech industry, providing analysis of pipelines, deals, and policy. It serves a similar investor, executive, and R&D professional audience and competes with PharmaVoice for pharma/biotech mindshare and ad budgets.

TypeDirect peer
Description

STAT is a B2B/B2C news publication covering biotech, pharma, and the life sciences, with deep reporting on drug development, policy, and industry leadership. It overlaps with PharmaVoice's coverage of pharma executives, R&D, and policy, and competes for similar advertiser demand.

3Pink Sheet (Citeline)
TypeDirect peer
Description

Pink Sheet, part of Citeline, is a long-running pharma industry intelligence publication covering regulatory, policy, and commercial developments. It targets similar pharma executive and regulatory affairs audiences as PharmaVoice and competes for sponsorship and premium content revenue.

TypeDirect peer
Description

BioPharma Dive is a sibling publication under Informa TechTarget covering biotech and pharma news. It shares PharmaVoice's parent company, audience overlap, and advertising sales infrastructure, making it both an internal benchmark and a partial substitute for advertisers.

TypeDirect peer
Description

Drug Discovery & Development is a B2B trade publication covering pharma R&D, drug discovery technologies, and laboratory science. It overlaps with PharmaVoice's R&D and Manufacturing topic coverage and competes for the same pharma services advertisers.

TypeDirect peer
Description

Endpoints News is a B2B digital publication covering the biopharmaceutical industry with breaking news, exclusive reporting, and paid subscriptions. It directly competes with PharmaVoice for both reader attention among pharma executives and advertiser/sponsor dollars in the same vertical.

TypeDirect peer
Description

BioSpace is a B2B digital media and jobs platform covering the biopharmaceutical industry, combining news coverage with career and employer branding services. It competes with PharmaVoice for pharma/biotech readership and for life sciences employer and service vendor advertising.

TypeDirect peer
Description

Pharmaceutical Executive is a long-standing B2B trade magazine and digital publication covering pharma business, leadership, and commercialization. It targets the same C-suite and senior pharma audience as PharmaVoice with overlapping editorial and advertiser categories.

9FiercePharma
TypeDirect peer
Description

FiercePharma is an established B2B trade publication covering pharmaceutical industry news, drug launches, and commercial strategy. It targets the same pharma/biotech executive and marketer audience as PharmaVoice and competes directly for ad and sponsorship revenue.

TypeDirect peer
Description

Xtelligent Pharma Life Sciences is a sibling publication under Informa TechTarget covering pharma and life sciences topics. It is co-branded alongside PharmaVoice on the TechTarget network page and competes directly for the same advertiser base within the parent's portfolio.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

PharmaVOICE

B2B Trade Media (Pharmaceutical & Biotech)pharmavoice.com

PharmaVoice is a B2B digital media trade publication operated by Informa TechTarget that delivers daily news, Q&A interviews, and executive profiles to pharmaceutical and biotech industry professionals, monetized via display advertising and sponsored content.

What PharmaVOICE does

PharmaVoice is a B2B digital media trade publication providing daily news, exclusive Q&A interviews, executive Profiles, and feature editorial to pharmaceutical and biotech industry professionals. Founded in 2001 and co-founded by Taren Grom (Editor-in-Chief Emeritus), the publication is operated by Informa TechTarget, a subsidiary of UK-listed Informa PLC, with operational headquarters in Needham, Massachusetts (headcount 11-50). The platform organizes content across eight topic verticals — Biotech, Commercialization, Leadership, Manufacturing, Patient, Pharma, Policy & Regulation, and Research & Development — and runs recurring series including First 90 Days, Trailblazers, Biotech Spotlight, A Day in the Life, and Opinion. The publication also operates the Library, a sponsored-content hub featuring playbooks, eBooks, webinars, and infographics from third-party sponsors including IQVIA, Cardinal Health, Certara, WCG, Premier Research, Lonza, Resilience, and Quest Diagnostics. Distribution is digital-only via the PharmaVoice website, a free daily newsletter, and social channels including LinkedIn, Facebook, and X.

The business model is sales-led advertising: PharmaVoice sells display advertising, sponsored editorial placements, and event listing promotions to pharmaceutical companies, CROs, biotech firms, and life sciences service providers seeking access to its professional readership. Content is free to readers with no paywall; monetization is entirely advertiser-funded. Revenue streams include display and digital advertising, sponsored content/branded content, event promotion and listings, and the free newsletter used as a lead-generation mechanism for advertisers. PharmaVoice sits within Informa TechTarget's life sciences media portfolio alongside sister publications BioPharma Dive and Xtelligent Pharma Life Sciences, benefiting from shared sales infrastructure and cross-brand audience reach. In 2025, the publication discontinued its annual PharmaVoice 100 recognition program and transitioned to year-round editorial coverage of standout industry leaders.

PharmaVOICE firmographics

Firmographics
Name
PharmaVOICE
Legal name
TechTarget, Inc.
Website
https://pharmavoice.com
Company type
Private
Founded year
2001
Operating status
Operating
Headcount range
1–10 employees
Short description
PharmaVoice is a B2B digital media trade publication operated by Informa TechTarget that delivers daily news, Q&A interviews, and executive profiles to pharmaceutical and biotech industry professionals, monetized via display advertising and sponsored content.
Ownership category
akta.pro rank

PharmaVOICE industry classification

Industry
Product category
B2B Trade Media (Pharmaceutical & Biotech)
NAICS
Periodical Publishers (513120), Other Publishers (51319)
SIC
Services-Advertising Agencies (7311)
akta.pro industry
PRIMARYEDAGAGAA
Medical & Clinical Reference (Physicians, Nursing, Allied Health)
Education/Educational Publishing & Learning Content/Professional & Technical Reference Publishing

Keywords

  • Pharmaceutical industry news
  • Biotech editorial coverage
  • B2B trade media
  • Sponsored content publishing
  • Executive Q&A interviews

Where PharmaVOICE is headquartered

Location

Headquarters

HQ city
Washington
HQ country
United States
HQ region
North America

Offices1 record

Markets served

PharmaVOICE business model

Business model
GTM type
B2B
Offering type
Digital Commerce or Content
Cost components
Personnel, Marketing or Sales, Operations, Technology or R&D, Others

Revenue model

  1. Display and digital advertising: PharmaVoice sells digital advertising placements including banner ads, sponsored content, and branded editorial features to pharma and biotech companies, CROs, and life sciences vendors seeking to reach industry professionals.
  2. Sponsored content and branded content: The publication features sponsored reports, playbooks, webinars, and infographics from third-party sponsors including pharmaceutical services companies (IQVIA, Cardinal Health, Certara, WCG, Premier Research, Lonza, etc.), presented within the PharmaVoice Library section.
  3. Event promotion and listings: PharmaVoice promotes industry events (conferences, forums) on its Events page and sells event listing services to organizers, driving revenue through event promotion fees.
  4. Free newsletter (lead generation): PharmaVoice offers a free daily newsletter delivering top industry headlines, which serves as a primary lead generation and audience retention mechanism, supporting the advertising business model.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels7 records

PharmaVOICE product offering

Product offering

Core offering

PharmaVoice is a digital-first B2B trade media publication that delivers pharmaceutical and biotech industry news, exclusive Q&A interviews with executives, opinion and editorial features, and a sponsored content library to pharma and biotech professionals worldwide. It operates a free daily newsletter and an annual PharmaVoice 100 recognition program, with revenue generated from display advertising, sponsored content, and event promotion sold to pharma advertisers and service providers.

Product overview

PharmaVOICE is a digital pharmaceutical industry news publication operated by Informa TechTarget. The platform delivers comprehensive coverage through multiple content sections including news articles, Q&A interviews with industry leaders, executive profiles, Biotech Spotlight features on emerging companies, and the First 90 Days series profiling executives in new roles. The publication organizes content across key topic areas including Biotech, Commercialization, Leadership, Manufacturing, Patient topics, Policy & Regulation, and Research & Development. Supporting offerings include Library Resources (whitepapers and industry reports), Events listings, Press Releases, and the PharmaVoice 100 recognition program honoring industry leaders. The platform serves pharma and biotech professionals seeking industry news, insights, and perspectives.

Differentiator

Problem solved

Functional benefit

Products and services

  • PharmaVoice Digital News Platform A digital, editorially driven pharmaceutical and biotech industry news publication distributed freely via pharmavoice.com across eight topic areas: Biotech, Commercialization, Leadership, Manufacturing, Patient, Pharma, Policy & Regulation, and Research & Development. It serves C-suite executives, R&D leaders, and clinical research professionals with news, Q&A interviews, executive profiles, opinion pieces, and trend coverage.
  • PharmaVoice Daily Newsletter A free daily email newsletter delivering top pharmaceutical and biotech industry headlines and featured stories. It functions as the publication's primary audience acquisition and retention channel and supports the advertiser-funded business model.
  • PharmaVoice 100 Recognition Program An annual nomination-driven recognition program honoring 100 outstanding leaders across 10 categories: Standout Leaders, Clinical Trial Pros, Trailblazers, Patient Champions, Biotech Pathfinders, Cancer Care Visionaries, Cardiometabolic All-stars, Cell and Gene Therapy Pioneers, Rare Disease Warriors, and Tech and AI Wizards. Historically received hundreds of nominations annually.
  • PharmaVoice Library (Sponsored Content Hub) A sponsored content resource hub on pharmavoice.com that hosts whitepapers, playbooks, webinars, infographics, and eBooks produced by pharma services sponsors. Sold as branded editorial placements to advertisers seeking lead generation and thought leadership reach with pharma decision-makers.
  • PharmaVoice Events Listings and Promotion A listing and promotional service on the PharmaVoice Events page for industry conferences and forums (e.g., Cardiovascular Forum, Oncology Forum, AnalytiCon), driving audience registration for event organizers through PharmaVoice's newsletter and editorial reach.

Companies that use PharmaVOICE

Customer profile

Segments3 records

Ideal customer profiles2 records

PharmaVOICE technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

PharmaVOICE partnerships and signals

Strategic signal

Partnerships

13 partnerships are on record, tiered core and minor.

  • Informa TechTargetcoreOthersPharmaVoice is owned and operated by Informa TechTarget, a global media network that informs, influences, and connects technology buyers and sellers. Informa TechTarget provides the operational infrastructure, advertising sales organization, and publishing platform for PharmaVoice. PharmaVoice is part of a portfolio that includes BioPharma Dive, Xtelligent Pharma Life Sciences, and other industry publications within the Informa PLC group.
  • Informa PLCcoreOthersInforma TechTarget is a subsidiary of Informa PLC, a UK-based international events, scholarly publishing, and information company. Informa PLC provides corporate ownership, brand backing, and strategic direction for TechTarget's media properties including PharmaVoice.
  • BioPharma DiveminorOthersBioPharma Dive is another publication under the Informa TechTarget umbrella, covering biotech and pharma news. The two publications share the same parent company and together form a broader pharma and biotech media network within TechTarget.
  • Xtelligent Pharma Life SciencesminorOthersXtelligent Pharma Life Sciences is another publication within the Informa TechTarget network covering pharma and life sciences topics. It is co-branded alongside PharmaVoice on the TechTarget network page.
  • IQVIAminorGTM or Marketing PartnerIQVIA sponsors content on PharmaVoice's Library page, including a playbook titled 'Translating Obesity Research to De-Risk Future GLP-1 Trials.' This is a paid content sponsorship arrangement where IQVIA provides educational content to PharmaVoice's audience.
  • Cardinal HealthminorGTM or Marketing PartnerCardinal Health sponsors an infographic on PharmaVoice's Library page titled 'Linked real-world data: More context, more completeness.' This is a sponsored content arrangement where Cardinal Health provides educational content to PharmaVoice's pharma professional audience.
  • Quest DiagnosticsminorGTM or Marketing PartnerQuest Diagnostics sponsors predictive analytics content on PharmaVoice's Commercialization topic page, promoting diagnostic insights as launch strategies for pharma companies.
  • CertaraminorGTM or Marketing PartnerCertara sponsors an eBook on PharmaVoice's Library page titled 'Rethinking Animal Testing and Drug Development,' providing educational content to the pharma R&D audience.
  • WCG (WCGIRB)minorGTM or Marketing PartnerWCG sponsors multiple content pieces on PharmaVoice's Library page, including playbooks on protocol design and data-informed clinical trial design, as well as an infographic on IRB submission checklists.
  • Premier ResearchminorGTM or Marketing PartnerPremier Research sponsors playbooks on PharmaVoice's Library page covering topics including the single pivotal clinical trial era and strategies for avoiding costly protocol amendments.
  • LonzaminorGTM or Marketing PartnerLonza sponsors a webinar on PharmaVoice's Library page titled 'Scaling Microbial Early Decisions into Commercial Readiness,' providing educational content on manufacturing and bioprocess topics.
  • Resilience (National Resilience Inc.)minorGTM or Marketing PartnerResilience sponsors CAR-T manufacturing content on PharmaVoice's Library page, including a sponsored Q&A on DAR-T platform technology for cell therapy manufacturing and an article on integrated data systems for clinical development.
  • The Health Management AcademyminorGTM or Marketing PartnerThe Health Management Academy (HMAcademy) partners with PharmaVoice to promote its Cardiovascular Forum and Oncology Forum events on PharmaVoice's Events page. PharmaVoice serves as a promotional channel for HMAcademy's industry events.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

PharmaVOICE competitors and assessment

Company assessment

Direct peers

  • BioCentury: BioCentury is a B2B intelligence and news publication focused on the biotech industry, providing analysis of pipelines, deals, and policy. It serves a similar investor, executive, and R&D professional audience and competes with PharmaVoice for pharma/biotech mindshare and ad budgets.
  • STAT News: STAT is a B2B/B2C news publication covering biotech, pharma, and the life sciences, with deep reporting on drug development, policy, and industry leadership. It overlaps with PharmaVoice's coverage of pharma executives, R&D, and policy, and competes for similar advertiser demand.
  • Pink Sheet (Citeline): Pink Sheet, part of Citeline, is a long-running pharma industry intelligence publication covering regulatory, policy, and commercial developments. It targets similar pharma executive and regulatory affairs audiences as PharmaVoice and competes for sponsorship and premium content revenue.
  • BioPharma Dive: BioPharma Dive is a sibling publication under Informa TechTarget covering biotech and pharma news. It shares PharmaVoice's parent company, audience overlap, and advertising sales infrastructure, making it both an internal benchmark and a partial substitute for advertisers.
  • Drug Discovery & Development: Drug Discovery & Development is a B2B trade publication covering pharma R&D, drug discovery technologies, and laboratory science. It overlaps with PharmaVoice's R&D and Manufacturing topic coverage and competes for the same pharma services advertisers.
  • Endpoints News: Endpoints News is a B2B digital publication covering the biopharmaceutical industry with breaking news, exclusive reporting, and paid subscriptions. It directly competes with PharmaVoice for both reader attention among pharma executives and advertiser/sponsor dollars in the same vertical.
  • BioSpace: BioSpace is a B2B digital media and jobs platform covering the biopharmaceutical industry, combining news coverage with career and employer branding services. It competes with PharmaVoice for pharma/biotech readership and for life sciences employer and service vendor advertising.
  • Pharmaceutical Executive: Pharmaceutical Executive is a long-standing B2B trade magazine and digital publication covering pharma business, leadership, and commercialization. It targets the same C-suite and senior pharma audience as PharmaVoice with overlapping editorial and advertiser categories.
  • FiercePharma: FiercePharma is an established B2B trade publication covering pharmaceutical industry news, drug launches, and commercial strategy. It targets the same pharma/biotech executive and marketer audience as PharmaVoice and competes directly for ad and sponsorship revenue.
  • Xtelligent Pharma Life Sciences: Xtelligent Pharma Life Sciences is a sibling publication under Informa TechTarget covering pharma and life sciences topics. It is co-branded alongside PharmaVoice on the TechTarget network page and competes directly for the same advertiser base within the parent's portfolio.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

PharmaVOICE social profiles

Digital presence

PharmaVOICE financial estimates

Financial estimate

Revenue estimate

Valuation estimate

PharmaVOICE leadership team

Management profile

Number of profiles

Profiles1 record

PharmaVOICE funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

PharmaVOICE M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about PharmaVOICE

What does PharmaVOICE do?

PharmaVoice is a digital-first B2B trade media publication that delivers pharmaceutical and biotech industry news, exclusive Q&A interviews with executives, opinion and editorial features, and a sponsored content library to pharma and biotech professionals worldwide. It operates a free daily newsletter and an annual PharmaVoice 100 recognition program, with revenue generated from display advertising, sponsored content, and event promotion sold to pharma advertisers and service providers.

Is PharmaVOICE a public or private company?

PharmaVOICE is a private company. It is classified as corporate owned and is currently operating.

When was PharmaVOICE founded?

PharmaVOICE was founded in 2001. It employs 1 to 10 people.

Where is PharmaVOICE based?

PharmaVOICE is headquartered in Washington, United States, in the North America region.

How does PharmaVOICE make money?

Four revenue lines are on record. Display and digital advertising is the primary driver. The others are sponsored content and branded content, event promotion and listings and free newsletter (lead generation).

Who are PharmaVOICE's main competitors?

Direct peers on record are BioCentury, STAT News, Pink Sheet (Citeline), BioPharma Dive, Drug Discovery & Development, Endpoints News, BioSpace, Pharmaceutical Executive, FiercePharma and Xtelligent Pharma Life Sciences.

Does PharmaVOICE have an API?

No public API is recorded for PharmaVOICE.

What industry is PharmaVOICE in?

PharmaVOICE's product category is B2B Trade Media (Pharmaceutical & Biotech). Its primary akta.pro industry code is EDAGAGAA, Medical & Clinical Reference (Physicians, Nursing, Allied Health). Its NAICS code is 513120 and its SIC code is 7311.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
GlobeNewswireEr-Kim CEO Cem Zorlular Recognized as a Patient Champion on the 2024 PharmaVoice 100Cem Zorlular, CEO of Er-Kim, was named a Patient Champion on the 2024 PharmaVoice 100. Er-Kim, which covers over 30 countries, aims to ensure patients have safe and prompt access to innovative treatments. The company continues to expand its geographic reach.GlobeNewswireAvalyn CEO Lyn Baranowski Named a PharmaVoice 100 HonoreeAvalyn Pharma CEO Lyn Baranowski was named to the 2024 PharmaVoice 100 list of inspiring life sciences leaders. She joined Avalyn in 2022 and oversaw a $175M Series C and Phase 2b/1b studies for inhaled therapies. She remains committed to advancing the company's portfolio for pulmonary fibrosis.GlobeNewswireParexel’s Teri Karcher Named to 2024 PharmaVoice 100Parexel announced that Teri Karcher, Chief Drug Development Officer and Executive Vice President, Head of Launch Excellence, was named to the 2024 PharmaVoice 100 list of inspirational life sciences leaders. She was recognized for her innovative approach to drug development and for strengthening Parexel's site relationships, which earned the company the SCRS Eagle Award for the second consecutive year.The Manila TimesParexel's Teri Karcher Named to 2024 PharmaVoice 100Parexel announced that Teri Karcher, Chief Drug Development Officer and Executive Vice President, has been named to the 2024 PharmaVoice 100 list of inspirational life sciences leaders. She was recognized for her innovative approach and efforts in forging new paths in drug development, including strengthening site relationships. The company also noted her leadership in establishing the Global Launch Excellence team.TmcnetBPGbio CEO Dr. Niven R. Narain Honored as PharmaVoice 100 Winner for Pioneering Work in AI-Driven Drug DiscoveryBPGbio CEO Dr. Niven Narain was named a PharmaVoice 100 winner for his AI-driven drug discovery work. His company's NAi platform has generated over 250 drug targets, and its candidate BPM31510 IV received FDA Rare Pediatric Disease designation for Primary CoQ10 Deficiency. The company is advancing phase 2 trials for aggressive cancers and planning late-stage trials.TmcnetParexel's Teri Karcher Named to 2024 PharmaVoice 100Parexel's Teri Karcher, Chief Drug Development Officer and Executive Vice President, was named to the 2024 PharmaVoice 100 list of inspirational life sciences leaders. She was recognized for her innovative approach to drug development and for strengthening Parexel's site relationships, which earned the company the SCRS Eagle Award for the second consecutive year.Industry DiveAnnouncing the 2024 PharmaVoice 100 Honorees: Celebrating Leaders Propelling Pharma ForwardPharmaVoice announced the 2024 PharmaVoice 100 honorees, recognizing leaders across the life sciences industry. The honorees span 10 categories, including cancer care, biotech, and AI, and the list has been published since 2005.YahooBPGbio CEO Dr. Niven R. Narain Honored as PharmaVoice 100 Winner for Pioneering Work in AI-Driven Drug DiscoveryBPGbio CEO Dr. Niven Narain was named a PharmaVoice 100 winner for his AI-driven drug discovery work. His company's NAi platform has generated over 250 drug targets, and its candidate BPM31510 IV received FDA Rare Pediatric Disease designation for Primary CoQ10 Deficiency. The company is advancing phase 2 trials for aggressive cancers and planning late-stage trials.Business Wire BlogBPGbio CEO Dr. Niven R. Narain Honored as PharmaVoice 100 Winner for Pioneering Work in AI-Driven Drug DiscoveryBPGbio CEO Dr. Niven Narain was named a PharmaVoice 100 winner for his AI-driven drug discovery work. Under his leadership, the company's NAi platform has generated over 250 drug targets and its candidate BPM31510 IV received FDA Rare Pediatric Disease designation for Primary CoQ10 Deficiency. The company continues late-stage trials for glioblastoma and pancreatic cancer.GlobeNewswireParexel’s Teri Karcher Named to 2024 PharmaVoice 100Parexel announced that Teri Karcher, Chief Drug Development Officer and Executive Vice President, Head of Launch Excellence, was named to the 2024 PharmaVoice 100 list of inspirational life sciences leaders. She was recognized for her innovative approach to drug development and for strengthening Parexel's site relationships, which earned the company the SCRS Eagle Award for the second consecutive year.